Loading...
Please wait, while we are loading the content...
Review of Oral Iron Chelators ( Deferiprone and Deferasirox ) for the Treatment of Iron Overload in Pediatric Patients
| Content Provider | Semantic Scholar |
|---|---|
| Author | Algren, D. Adam |
| Copyright Year | 2011 |
| Abstract | PROPOSAL The World Health Organization Model List of Essential Medicines and Model Formulary 2010 list deferoxamine (DFO) as the treatment of choice for both acute and chronic iron poisoning. The Model Formulary currently does not designate any orally administered agents for the chelation of iron. It is proposed that deferasirox be considered the oral chelator of choice in the treatment of chronic iron overload. Deferasirox is widely available recent evidence support that it is both safe and efficacious. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.docum-enter.com/get/wi-U20ZVheJLGwcLWRr_TX33bdL9twTRh4ZYQfEp0L0,/Review-of-Oral-Iron-Chelators-Deferiprone-and.pdf |
| Alternate Webpage(s) | http://www.who.int/selection_medicines/committees/expert/18/applications/OralIronChelators.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |